You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Guaifenesin; hydrocodone bitartrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for guaifenesin; hydrocodone bitartrate and what is the scope of freedom to operate?

Guaifenesin; hydrocodone bitartrate is the generic ingredient in four branded drugs marketed by Chartwell Rx, Sovereign Pharms, and Eci Pharms Llc, and is included in four NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for guaifenesin; hydrocodone bitartrate
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for guaifenesin; hydrocodone bitartrate
Generic Entry Date for guaifenesin; hydrocodone bitartrate*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for guaifenesin; hydrocodone bitartrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Reckitt Benckiser LLCPhase 1

See all guaifenesin; hydrocodone bitartrate clinical trials

Pharmacology for guaifenesin; hydrocodone bitartrate

US Patents and Regulatory Information for guaifenesin; hydrocodone bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sovereign Pharms OBREDON guaifenesin; hydrocodone bitartrate SOLUTION;ORAL 205474-001 Nov 14, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Chartwell Rx HYCOFENIX guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride SOLUTION;ORAL 022279-001 May 14, 2015 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sovereign Pharms OBREDON guaifenesin; hydrocodone bitartrate SOLUTION;ORAL 205474-001 Nov 14, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Chartwell Rx FLOWTUSS guaifenesin; hydrocodone bitartrate SOLUTION;ORAL 022424-001 May 14, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eci Pharms Llc XTRELUS guaifenesin; hydrocodone bitartrate TABLET;ORAL 208085-001 Apr 25, 2018 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.